AlphAIAlphAI — Financial news for AI agents
rttnews.comOCT 221 min read$DGX

Quest Diagnostics Boosts FY26 Outlook - Update

Quest Diagnostics (DGX) raised its FY26 outlook, now expecting earnings of $10.21-$10.31 per share, adjusted earnings of $11.25-$11.35 per share, and revenue of $12.065-$12.105 billion. Previously, it forecasted earnings of $9.97-$10.17 per share, adjusted earnings of $11.05-$11.25 per share, and revenue of $11.95-$12.05 billion. DGX shares are trading at $238.90 in pre-market.

Original reporting
rttnews.com
Published Oct 22, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 12:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Quest Diagnostics Boosts FY26 Outlook - Update — source image
Source · rttnews.com
Decision brief

The 30-second read

$DGXNeutralHigh
01

Why it matters

The guidance lift signals improved operational performance, but the minimal pre‑market price move suggests the market may have anticipated the improvement.

02

Market read

Guidance update provides a fresh data point for traders to adjust positions in DGX and related health‑care service stocks.

03

What to watch

Potential cost pressures or payer reimbursement changes could offset the guidance upside.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Quest Diagnostics reported Q3 results and simultaneously upgraded its FY26 earnings and revenue guidance.

Company-level read

Ticker impact

$DGXNeutralHigh confidence
Context

Quest Diagnostics raised its FY26 earnings and revenue guidance, announcing higher EPS and revenue ranges.

Expected impact

likely slight upward pressure as the market prices in the higher guidance

Evidence & confidence

Guidance is materially higher than prior estimates, but the move in pre‑market trading was negligible, indicating limited immediate reaction.

Market effects

Sector

Higher diagnostic‑services earnings outlook may lift peer valuations in the healthcare services sector.

Regional

U.S. healthcare stocks could see modest gains as investors reassess earnings forecasts.

Global

Limited; impact confined to U.S. diagnostic and broader health‑care equities.

Counterpoint

What could challenge this read

If the guidance increase is already priced in, the stock could face disappointment on actual results.

Key entities

  • company
    Quest Diagnostics, Inc.

    Diagnostic services firm listed on NYSE under ticker DGX.

Read at source← All news

StoryQuest Diagnostics posts Q3 2026 results, raises full‑year revenue and EPS outlook

Also covered by

6 outlets

Related articles

OCT 22
$DGXLow

Quest Diagnostics Reports Hack on IT System Used by Clients

Quest Diagnostics reported a cyber incident involving its Quanum Lab Services Manager system, potentially compromising certain patient records. The company paused access to the system while investigating but stated it has not materially disrupted operations. Quest notified U.S. law enforcement and is taking remedial measures. The company reported $11.04 billion in revenue for 2025. This follows recent cyber incidents at Abbott Labs, which is facing lawsuits.

govinfosecurity.com2 min
OCT 22
$DGXMed

Quest Diagnostics Inc (DGX) (Q3 2026) Earnings Call Highlights: Double-Digit Revenue

Quest Diagnostics (DGX) reported Q3 2026 earnings with double-digit revenue growth, but faces challenges. PAMA reimbursement cuts may impact 2027 revenues by 1%. Total revenue per requisition declined 4.2% due to business mix, though it rose 1.7% excluding certain relationships. The company also reported a cybersecurity incident and higher fuel costs. CEO Jim Davis and CFO Sam Samad discussed growth strategies, partnerships, and margin improvements.

finance.yahoo.com3 min
OCT 22
$DGXMed

Northern Light Health lab manager suffers data breach

Quest Diagnostics reported a cyber breach in its Quanum Lab Services Manager, potentially compromising patient records. The breach, discovered Wednesday, is under investigation. Quest manages labs for Northern Light Health, which stated no indication of its patients being impacted. Quest has notified law enforcement and is working with cybersecurity experts. The company has experienced similar breaches in 2016 and 2019.

wabi.tv2 min
OCT 22
$DGXHighAI 8/10

What Quest Diagnostics (DGX) Said on Its Q3 Earnings Call

Quest Diagnostics (DGX) reported Q3 operating income of $479M, up from $386M YoY. Adjusted EPS rose 15.4% to $3.00. The company expects full-year 2026 revenue of $12.065B-$12.105B. Quest plans to acquire select assets from a health system in the Northeastern U.S. and launched consumer health services via Apple Health app. Management addressed PAMA concerns, estimating a 1% revenue impact in 2027.

finance.yahoo.com2 min
OCT 22
$DGXHighAI 8/10

Quest Diagnostics (DGX) Q3 2026 Earnings Call Transcript

Quest Diagnostics (DGX) raised its full-year revenue and earnings guidance after Q3 2026, citing strong performance across physician, hospital, and consumer health channels. Key growth drivers include collaborations, acquisitions, and innovative solutions like Apple Health app integration. The company also announced plans to expand its Alzheimer's disease testing portfolio and improve operational efficiency through automation and AI.

finance.yahoo.com2 min